Selected extended-relief drugs targeted
232128
Manufacturers of unapproved extended-release cough and cold drugs that contain an expectorant called guaifenesin have until Nov. 25 to stop shipping the medicines, health officials said Friday.
287132
SAN ANTONIO, Dec. 8 /PRNewswire-FirstCall/ -- New data presented today from the world&#39;s largest early breast cancer treatment trial (ATAC) report that ARIMIDEX reduced the relative risk of breast cancer recurrence
402115
Two drugs provide good results in preliminary trials.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
41436
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
734839
Neurocrine resubmits a marketing application for its lead drug.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
58416
THURSDAY, Sept. 20 (HealthDay News) -- The current chemotherapy regimens of irinotecan, oxaliplatin, and molecular-targeted treatments are helping patients with advanced colorectal cancer live several months longer than they did a few years ago, when these therapies weren&#39;t available, Greek researchers say.
253298
The drug company pushes on after the Enhance trials.
62245
TUESDAY, Sept. 28 (HealthDayNews) -- Scientists call them &quot;molecularly targeted&quot; drugs, and they represent a remarkable gain in the war against blood cancers.
409638
Promising trials for a hepatitis C treatment bode well for the pharmaceutical.
332379
A drug used to treat advanced breast and lung cancers has been found to prolong the lives of men with advanced prostate cancer whose tumors don't respond to hormone therapy, according to two studies published on Wednesday.
717655
A kidney cancer drug became the first medicine to extend the life of patients with advanced liver cancer in a large study, adding about three months to survival compared with a placebo, according to a data released on Monday.
521918
The new Genentech, Inc., cancer drug Avastin appears to extend survival for patients with colorectal cancer by nearly two months, US National Cancer Institute researchers have concluded.
539674
OSI Pharmaceuticals Inc. OSIP.O said  on Thursday a new drug application for its drug Tarceva, used  to treat advanced non-small cell lung cancer, was accepted by  U.S. regulators for priority review.
451154
A drug approved last year as a last-ditch hope for some lung cancer patients who didn&#39;t find relief from other forms of therapy has come up short in a large clinical trial.